Related Experiment Video
Updated: Jun 2, 2026
08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Bariatric surgery: an IDF statement for obese Type 2 diabetes
J B Dixon1, P Zimmet, K G Alberti
1Baker IDI Heart and Diabetes Institute, 99 Commercial Road, Melbourne, Victoria, Australia.
Summary
Bariatric surgery offers an effective, safe, and cost-effective treatment for severely obese patients with Type 2 diabetes, significantly improving glycemic control when medical therapies fall short.
Area of Science:
- Endocrinology and Metabolic Diseases
- Surgical Interventions
- Public Health Policy
Background:
- Type 2 diabetes and obesity are significant global health challenges.
- Current medical therapies for Type 2 diabetes may not achieve optimal glycemic control in all patients, particularly those with severe obesity.
- Gastrointestinal interventions, including bariatric surgery, are increasingly considered for managing Type 2 diabetes.
Purpose of the Study:
- To review the role of surgery and gastrointestinal interventions in Type 2 diabetes treatment and prevention.
- To develop clinical recommendations for patient selection in bariatric surgery.
- To identify barriers to surgical access and propose health policy changes for equitable access.
Main Methods:
- Convened a consensus working group of diabetologists, endocrinologists, surgeons, and public health experts.
- Reviewed existing literature and clinical data on bariatric surgery for Type 2 diabetes.
- Formulated practical recommendations and identified research priorities.
Main Results:
- Bariatric surgery significantly improves glycemic control in severely obese patients with Type 2 diabetes.
- It is an effective, safe, and cost-effective therapy for obese Type 2 diabetes.
- Surgery is appropriate for patients not meeting treatment targets with medical therapies, especially with co-morbidities.
Conclusions:
- Bariatric surgery should be considered a treatment option for Type 2 diabetes and obesity under specific conditions.
- Procedures require adherence to guidelines, multidisciplinary assessment, patient education, and ongoing care.
- National guidelines for bariatric surgery in Type 2 diabetes patients with a BMI ≥35 kg/m² are needed.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...